The number of effector memory CD8+ (CD45RO+CCR7−CD8+) T cells in patients with COVID‐19 increased during the convalescent period (82 cells/μL [50‐144] vs 135 cells/μL [50‐166 cells/μL], P = 0.041, Figure 4A). This evidence concerns the gene CD8A and COVID-19.